A naukri.com initiative
The Robot Report
3w
222
ForSight Robotics raises $125M for cataract surgery tech
- ForSight Robotics completed a $125 million Series B funding round to support its ophthalmic robotic surgery tech.
- Eclipse led the financing, with an undisclosed strategic investor and Fred Moll, the father of surgical robotics, participating.
- The funding brought ForSight Robotics' total funding to $195 million.
- The company plans to use the funds to accelerate the growth phase for its Oryom platform, the world's first robotic surgery platform for cataracts and eye diseases.
- Oryom uses AI-based algorithms, advanced computer vision, and miniaturized mechanics for precise ophthalmic procedures.
- It offers improved ergonomic experience, dexterity, and maneuverability for surgeons.
- The platform allows access to anterior and posterior segments for glaucoma and retinal surgery treatments.
- ForSight Robotics aims to launch first-in-human clinical trials this year.
- The company sees ophthalmology as the next frontier in the robotics revolution and aims to bring transformative impact to eye surgery.
- The NHS of England plans to support half a million robotic operations annually by 2035, up from 70,000 in 2023 and 2024.
- Millions of patients are expected to benefit from robotic surgery efforts to reduce waiting times.
- The article was republished from sister website MassDevice.
- ForSight Robotics is focused on advancing robotic surgery technology for eye procedures.
- The company aims to address the precision and complexity unique to eye surgeries.
- The Oryom platform enables surgeons to navigate complex angles within the human eye.
- AI, computer vision, and miniaturized mechanics are utilized to perform eye surgeries.
- The funding round will facilitate the development and launch of innovative robotic solutions for ophthalmology.
Read Full Article
13 Likes
For uninterrupted reading, download the app